Potassium binders in heart failure: Who, when, and how
Faculty: Ileana L. Piña, MD, MPH, FAHA, FACC , Patrick Rossignol, MD, PhDMay 21, 2021
View this accredited e-learning program with a focus on heart failure at our partner website ReachMD, a leading online learning platform for physicians and other healthcare professionals
Clinicians often struggle to optimize guideline-directed medical therapy in patients with heart failure and frequently lower RAASi therapies in response to episodes of hyperkalemia, which translates into an increased risk for poor outcomes. But what if there was a better way to lower potassium levels so that these patients could reach those target doses?
This activity will cover the screening and monitoring strategies for hyperkalemia in patients with heart failure as well as how to utilize newer potassium binders to maximize guideline-recommended RAASi therapy.
- Ileana L. Piña, MD, MPH, FAHA, FACC, Professor of Medicine, Wayne State University, Detroit, MI
- Patrick Rossignol, MD, PhD, Professor, Université de Lorraine, Nancy, France
This activity is provided by Medtelligence and is supported by an independent educational grant from Vifor Pharma